萬寶盛華(02180.HK):2022年經調整純利1.32億元 末期息0.12港元
格隆匯3月30日丨萬寶盛華(02180.HK)發佈公吿,2022年,集團實現總營收人民幣45.88億元,較2021年同期增長約15.6%。靈活用工業務分部按年增長約17.8%至人民幣43.44億元。報吿期間內,公司擁有人應占純利減少至人民幣1.19億元,較去年負增長約14.8%。計及購股權開支及受限制股份單位開支以及商譽及其他無形資產減值虧損後,公司擁有人應占經調整純利減少至人民幣1.32億元,較去年下降約9.6%。董事建議在去年九月派發中期股息每股1.6港元的基礎上,就2022年度派發末期股息每股普通股0.12港元(相當於每股人民幣0.11元,佔集團每股股份盈利約20%),以回饋長期投資者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.